These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20658496)

  • 1. Determinants of paraoxonase activity in healthy adults.
    Boesch-Saadatmandi C; Rimbach G; Schrader C; Kofler BM; Armah CK; Minihane AM
    Mol Nutr Food Res; 2010 Dec; 54(12):1842-50. PubMed ID: 20658496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
    Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
    Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
    Sierksma A; van der Gaag MS; van Tol A; James RW; Hendriks HF
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1430-5. PubMed ID: 12351939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical, environmental, and genetic factors associated with paraoxonase (PON1) activity.
    Sirivarasai J; Kaojarern S; Sura T; Yoovathaworn K
    Biochem Genet; 2011 Jun; 49(5-6):364-8. PubMed ID: 21258965
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic and environmental determinants of the PON-1 phenotype.
    Roest M; van Himbergen TM; Barendrecht AB; Peeters PH; van der Schouw YT; Voorbij HA
    Eur J Clin Invest; 2007 Mar; 37(3):187-96. PubMed ID: 17359486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
    Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF
    Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between PON 1 polymorphisms, PON activity and diabetes complications.
    Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
    J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of apolipoprotein E gene polymorphism to serum lipid concentrations in healthy Thais.
    Chanprasertyothin S; Ongphiphadhanakul B; Rajatanavin R; Piaseu N; Chailurkit LO; Puavilai G
    J Med Assoc Thai; 2000 Oct; 83(10):1233-9. PubMed ID: 11143490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
    Kumru S; Aydin S; Gursu MF; Ozcan Z
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):177-81. PubMed ID: 15140512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Voorbij HA; Sluiter WJ; van Tol A
    Eur J Clin Invest; 2009 Mar; 39(3):200-3. PubMed ID: 19260949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
    Paragh G; Törocsik D; Seres I; Harangi M; Illyés L; Balogh Z; Kovács P
    Curr Med Res Opin; 2004 Aug; 20(8):1321-7. PubMed ID: 15324535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
    Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
    Regieli JJ; Jukema JW; Doevendans PA; Zwinderman AH; Kastelein JJ; Grobbee DE; van der Graaf Y
    J Am Coll Cardiol; 2009 Sep; 54(14):1238-45. PubMed ID: 19778663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.